Published in

The Madrid-based company Peaches Biotech announced on Thursday the incorporation into its research project of a worldwide patent from Harvard University that makes it possible to identify and attack pancreatic tumor cells and other solid tumors such as colon or gastrointestinal secretory tumors. This project will be developed in conjunction with Manuel Hidalgo, M.D., chief of the Division of Hematology-Oncology at Weill Cornell Medicine and New York Presbyterian Hospital in New York, and the …

Read more:

This site is registered on as a development site.